Tag: URGN

Companies

Why Have UroGen Pharma Ltd (NASDAQ: URGN) Shares Declined So Much?

UroGen Pharma Ltd (NASDAQ:URGN) price closed higher on Monday, June 30, and jumping 1.56% above its previous close. A look at the daily price movement shows that the last close reads $13.49, with intraday deals fluctuated between $13.465 and $13.9273. The company’s 5Y monthly beta

Companies

UroGen Pharma Ltd (URGN) At $13.72: Is It Worth Your Interest?

UroGen Pharma Ltd (NASDAQ:URGN) concluded the trading at $13.72 on Wednesday, June 25 with a fall of -0.51% from its closing price on previous day. Considering stock’s 52-week price range provides that URGN hit a high price of $18.15 and saw its price falling to

Business

Why Is UroGen Pharma Ltd (NASDAQ: URGN) Gaining?

UroGen Pharma Ltd (NASDAQ:URGN) traded at $14.87 at close of the session on Friday, June 20 and made an upward move of 14.65% on its previous day’s price. Looking at the stock we see that its previous close was $34.38 and the beta (5Y monthly)

Companies

Investors Cash In On UroGen Pharma Ltd’s -4.75% Loss

UroGen Pharma Ltd (NASDAQ:URGN) price closed lower on Monday, June 09, and dropping -4.75% below its previous close. A look at the daily price movement shows that the last close reads $7.37. Taking into account the 52-week price action we note that the stock hit

Stocks Register
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.